Search for: "WILLIAM MAISEL"
Results 41 - 60
of 64
Sorted by Relevance
|
Sort by Date
10 Aug 2012, 11:30 am
., Inez Barron, James Brennan, Karim Camara, William Colton, Steven Cymbrowitz, Rhoda Jacobs, Joseph Lentol, Vito Lopez, Alan Maisel, Joan Millman, N. [read post]
15 May 2009, 1:46 am
William Maisel, cardiologist at Beth Israel Deaconess Medical Center and co-chair of the group's task force on lead performance. [read post]
12 May 2008, 2:46 pm
Committee on Oversight and Government ReformWednesday, May 14, 2008, 10:00 AM at 2154 Rayburn House Office Building It is expected that the Committee should offer live streaming video of this hearing on their website: http://www.oversight.house.gov At this May 2008 hearing, members of Congress and those in attendance will likely hear from each of these scheduled witnesses: Actor Dennis Quaid and his wife Kimberly, parents of newborn twins, Thomas Boone Quaid and Zoe Grace Quaid, who were victims… [read post]
24 Mar 2011, 9:00 am
"Obesity is a major public health concern in the United States," said William Maisel, M.D., M.P.H., deputy director for science at the FDA's Center for Devices and Radiological Health. [read post]
18 Jul 2011, 1:20 pm
"The FDA is asking surgeons to carefully consider all other treatment options and to make sure that their patients are fully informed of potential complications from surgical mesh," William Maisel, M.D., M.P.H., deputy director of FDA's center for devices and radiological health, said in a statement. [read post]
14 Jul 2011, 12:02 pm
”There are clear risks associated with the transvaginal placement of mesh to treat POP,” said William Maisel, M.D., M.P.H., deputy director and chief scientist of the FDA’s Center for Devices and Radiological Health. [read post]
29 Apr 2014, 8:58 pm
FDA takes a Stand According to William Maisel, M.D., M.P.H., deputy director of science and chief scientist at the FDA’s Center for Devices and Radiological Health, “the FDA has identified clear risks associated with surgical mesh for the transvaginal repair of pelvic organ prolapse and is now proposing to address those risks for more safe and effective products. [read post]
26 Jun 2023, 7:16 am
By Sophia Williams Launched in 2020, Warfare of Art & Law, a podcast hosted by attorney and artist Stephanie Drawdy, is a trove of conversations exploring how “justice does or doesn’t play out when art and law overlap. [read post]
6 May 2009, 3:01 pm
., Professor of Law, Georgetown University Law Center William H. [read post]
13 Jul 2011, 4:56 pm
“There are clear risks associated with the transvaginal placement of mesh to treat POP,” said William Maisel, M.D., M.P.H., deputy director and chief scientist at the FDA’s Center for Devices and Radiological Health. [read post]
6 Jan 2008, 9:09 pm
Maisel-Hollins Development Co. et al Young Again Products, Inc. v. [read post]
9 Sep 2011, 6:47 am
“The clinical effectiveness of surgical mesh for transvaginal repair of pelvic organ prolapse has not been demonstrated,” said William Maisel, deputy director of the FDA Center for Devices and Radiological Health, in a telephone interview. [read post]
17 Jul 2020, 2:20 pm
William H. [read post]
17 Jul 2020, 2:20 pm
William H. [read post]
28 Feb 2009, 4:00 pm
Lancman, Alan Maisel, Jose R. [read post]
15 Sep 2011, 10:28 pm
”There are clear risks associated with the transvaginal placement of mesh to treat POP,” said William Maisel, M.D., M.P.H., deputy director and chief scientist of the FDA’s Center for Devices and Radiological Health. [read post]
14 Jul 2011, 8:40 pm
William Maisel, the FDA’s deputy director of the Center for Devices and Radiological Health, “The evidence we reviewed calls into question the clinical benefit of mesh, and it certainly shouldn’t be used routinely for all transvaginal prolapsed repairs.'' In 2010, 75,000 women had vaginal surgery with mesh to repair pelvic organ prolapse. [read post]
9 Sep 2008, 2:32 pm
William H. [read post]
9 Sep 2011, 7:07 am
Second, Bloomberg News (9/8, Voreacos, Nussbaum) reported on the FDA report recommending the category change and quoting William Maisel, deputy director of the FDA Center for Devices and Radiological Health, saying, “The clinical effectiveness of surgical mesh for transvaginal repair of POP has not been demonstrated. [read post]
27 Aug 2011, 2:53 pm
In response to complaints, last month, William Maisel, deputy director of the FDA’s Center for Devices and Radiological Health, issued a statement saying, “There are clear risks associated with the transvaginal placement of mesh to treat pelvic organ prolapse,” adding, “The FDA…is asking surgeons to carefully consider all other treatment options. [read post]
